[HTML][HTML] SARS-CoV-2 ORF8: a rapidly evolving immune and viral modulator in COVID-19

A Arduini, F Laprise, C Liang - Viruses, 2023 - mdpi.com
The COVID-19 pandemic has resulted in upwards of 6.8 million deaths over the past three
years, and the frequent emergence of variants continues to strain global health. Although …

[HTML][HTML] Neutrophil extracellular traps and long COVID

A Shafqat, MH Omer, I Albalkhi… - Frontiers in …, 2023 - frontiersin.org
Post-acute COVID-19 sequelae, commonly known as long COVID, encompasses a range of
systemic symptoms experienced by a significant number of COVID-19 survivors. The …

[HTML][HTML] The effectiveness of a four-week digital physiotherapy intervention to improve functional capacity and adherence to intervention in patients with long COVID …

MJ Estebanez-Pérez, JM Pastora-Bernal… - International journal of …, 2022 - mdpi.com
Long COVID-19 has been defined as the condition occurring in individuals with a history of
probable or confirmed SARS-CoV-2 infection, with related symptoms lasting at least 2 …

Chronic pulmonary manifestations of COVID-19 infection: imaging evaluation

MC Murphy, BP Little - Radiology, 2023 - pubs.rsna.org
This case presents a patient with severe COVID-19 pneumonia requiring intensive care unit
admission and a prolonged hospital stay. The infection resulted in long-term morbidity …

[HTML][HTML] Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis

J Guiot, M Henket, C Remacle, M Cambier… - Respiratory …, 2023 - Springer
Background Pulmonary fibrosis is an emerging complication of SARS-CoV-2 infection. In
this study, we speculate that patients with COVID-19 and idiopathic pulmonary fibrosis (IPF) …

[HTML][HTML] Idiopathic pulmonary fibrosis and post-COVID-19 lung fibrosis: links and risks

F Patrucco, P Solidoro, F Gavelli, D Apostolo, M Bellan - Microorganisms, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

[HTML][HTML] Long-term effect of COVID-19 on lung imaging and function, cardiorespiratory symptoms, fatigue, exercise capacity, and functional capacity in children and …

C Campos, S Prokopich, H Loewen… - Healthcare, 2022 - mdpi.com
Background: The long-term sequela of COVID-19 on young people is still unknown. This
systematic review explored the effect of COVID-19 on lung imaging and function …

Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway‐Based Approach

LA Saarimäki, J Morikka, A Pavel… - Advanced …, 2023 - Wiley Online Library
Mechanistic toxicology provides a powerful approach to inform on the safety of chemicals
and the development of safe‐by‐design compounds. Although toxicogenomics supports …

[HTML][HTML] Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States

A Adegunsoye, R Baccile, TJ Best, V Zaksas… - The Lancet Regional …, 2023 - thelancet.com
Background Pulmonary fibrosis is characterized by lung parenchymal destruction and can
increase morbidity and mortality. Pulmonary fibrosis commonly occurs following …

[HTML][HTML] Alveolar macrophage phagocytosis-evading inhaled microgels incorporating nintedanib-PLGA nanoparticles and pirfenidone-liposomes for improved …

WT Lee, H Lee, J Kim, Y Jung, E Choi, JH Jeong… - Bioactive Materials, 2024 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic inflammatory and fibrotic response-driven
lung disease that is difficult to cure because it manifests excessive profibrotic cytokines (eg …